Medical Oncology

, Volume 29, Issue 3, pp 1780–1788 | Cite as

Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer

  • Feng Wang
  • Peng Zhang
  • Chenzhang Shi
  • Yongzhi Yang
  • Huanlong Qin
Original Paper


The present study was aimed at evaluating the expression of heat shock protein 27 (HSP27) and heterogeneous nuclear ribonucleoprotein K (hnRNP K), two potential biomarkers of many cancers, in colorectal cancer (CRC) and their clinical significance. Expression of HSP27 and hnRNP K were investigated by immunohistochemistry (IHC) in a series of tissue microarrays containing 175 primary colorectal cancers and their corresponding normal mucosa samples and matched with clinicopathological features and patient survival. HSP27 and hnRNP K displayed more frequent strong immunoreactivity in primary colorectal tumor samples compared with adjacent non-cancer tissue (P < 0.001). Increased cytoplasmic expression of HSP27 and hnRNP K were associated with tumor location (P = 0.032 and P < 0.001, respectively), poorer overall survival (P = 0.004 and P = 0.02, respectively) and to an unfavorable prognosis for CRC patients in multivariate analysis (P = 0.019 and P = 0.01, respectively). Their overexpression combination identified a subset of patients with definitively worse prognosis than any other combination (P < 0.001). Overexpression of HSP27 and hnRNPK were independent markers of poor prognosis, and their combination predicted definitively adverse outcomes in CRC patients.


Colorectal cancer Immunohistochemistry Tissue microarray Prognosis Heat shock protein 27 (HSP27) Heterogeneous nuclear ribonucleoprotein K (hnRNP K) 



Colorectal cancer




Tissue microarray


Heat shock protein 27


Heterogeneous nuclear ribonucleoprotein K


  1. 1.
    Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectalcancer. CA Cancer J Clin. 2009;59:366–78.PubMedCrossRefGoogle Scholar
  2. 2.
    O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Celis JE, Gromov P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell. 2003;3:9–15.PubMedCrossRefGoogle Scholar
  4. 4.
    Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol. 2005;23:3526–35.PubMedCrossRefGoogle Scholar
  5. 5.
    Kim IJ, Lim SB, Kang HC, et al. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum. 2007;50:1342–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Battifora H, Mehta P. The checkerboard tissue block. An improved multitissue control block. Lab Invest. 1990;63:722–4.PubMedGoogle Scholar
  7. 7.
    Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosen DG, Huang X, Deavers MT, et al. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol. 2004;17:790–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Kleiner HE, Krishnan P, Tubbs J, et al. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. J Exp Clin Cancer Res. 2009;28:5.Google Scholar
  10. 10.
    Zhang P, Huang L, Ma YL, et al. HnRNP K and PDI marked response to chemotherapy to human colorectal cancer cells. Electrophoresis. 2010;31:1731–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Liu W, Ma Y, Huang L, et al. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol Biol Rep. 2010;37:3207–16.PubMedCrossRefGoogle Scholar
  12. 12.
    Walter SD, Feinstein AR, Wells CK. A comparison of multivariable mathematical methods for predicting survival–II. Statistical selection of prognostic variables. J Clin Epidemiol. 1990;43:349–59.PubMedCrossRefGoogle Scholar
  13. 13.
    Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10:86–103.PubMedCrossRefGoogle Scholar
  14. 14.
    Kurahashi T, Miyake H, Hara I, Fujisawa M. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. J Urol. 2007;177:757–61.PubMedCrossRefGoogle Scholar
  15. 15.
    Foster CS, Dodson AR, Ambroisine L, et al. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer. 2009;101:1137–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Geisler JP, Tammela JE, Manahan KJ, et al. HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up. Eur J Gynaecol Oncol. 2004;25:165–8.PubMedGoogle Scholar
  17. 17.
    Kapranos N, Kominea A, Konstantinopoulos PA, et al. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol. 2002;128:426–32.PubMedCrossRefGoogle Scholar
  18. 18.
    Feng JT, Liu YK, Song HY, et al. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics. 2005;5:4581–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Geisler JP, Geisler HE, Tammela J, et al. A study of heat shock protein 27 in endometrial carcinoma. Gynecol Oncol. 1999;72:347–50.PubMedCrossRefGoogle Scholar
  20. 20.
    Nakajima M, Kuwano H, Miyazaki T, et al. Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett. 2002;178:99–106.PubMedCrossRefGoogle Scholar
  21. 21.
    Wang A, Liu X, Sheng S, et al. Dysregulation of heat shock protein 27 expression in oral tongue squamous cell carcinoma. BMC Cancer 2009;9:167.Google Scholar
  22. 22.
    Pei H, Zhu H, Zeng S, et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res. 2007;6:2495–501.PubMedCrossRefGoogle Scholar
  23. 23.
    Zhao L, Liu L, Wang S, et al. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. J Cancer Res Clin Oncol. 2007;133:771–82.PubMedCrossRefGoogle Scholar
  24. 24.
    Tweedle EM, Khattak I, Ang CW, et al. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut. 2010;59:1501–10.PubMedCrossRefGoogle Scholar
  25. 25.
    Frattini M, Balestra D, Suardi S, et al. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res. 2004;10:4015–21.PubMedCrossRefGoogle Scholar
  26. 26.
    Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem. 1993;62:289–321.PubMedCrossRefGoogle Scholar
  27. 27.
    He Y, Smith R. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci. 2009;66:1239–56.PubMedCrossRefGoogle Scholar
  28. 28.
    Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays. 2004;26:629–38.PubMedCrossRefGoogle Scholar
  29. 29.
    Carpenter B, McKay M, Dundas SR, et al. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer. 2006;95:921–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Klimek-Tomczak K, Mikula M, Dzwonek A, et al. Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa. Br J Cancer. 2006;94:586–92.PubMedCrossRefGoogle Scholar
  31. 31.
    Hope NR, Murray GI. The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol. 2011;42:393–402.PubMedCrossRefGoogle Scholar
  32. 32.
    Evans JR, Mitchell SA, Spriggs KA, et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene. 2003;22:8012–20.PubMedCrossRefGoogle Scholar
  33. 33.
    Lee PT, Liao PC, Chang WC, Tseng JT. Epidermal growth factor increases the interaction between nucleolin and heterogeneous nuclear ribonucleoprotein K/poly(C) binding protein 1 complex to regulate the gastrin mRNA turnover. Mol Biol Cell. 2007;18:5004–13.PubMedCrossRefGoogle Scholar
  34. 34.
    Notari M, Neviani P, Santhanam R, et al. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood. 2006;107:2507–16.PubMedCrossRefGoogle Scholar
  35. 35.
    Inoue A, Sawata SY, Taira K, Wadhwa R. Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis. Proc Natl Acad Sci USA. 2007;104:8983–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Neo JC, Rose P, Ong CN, Chung MC. Beta-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics. 2005;5:1075–82.PubMedCrossRefGoogle Scholar
  37. 37.
    Rose P, Armstrong JS, Chua YL, et al. Beta-phenylethyl isothiocyanate mediated apoptosis; contribution of Bax and the mitochondrial death pathway. Int J Biochem Cell Biol. 2005;37:100–19.PubMedCrossRefGoogle Scholar
  38. 38.
    Rahman-Roblick R, Roblick UJ, Hellman U, et al. p53 targets identified by protein expression profiling. Proc Natl Acad Sci USA. 2007;104:5401–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Feng Wang
    • 1
  • Peng Zhang
    • 1
  • Chenzhang Shi
    • 1
  • Yongzhi Yang
    • 1
  • Huanlong Qin
    • 1
  1. 1.Department of SurgeryThe Sixth People’s Hospital Affiliated to Shanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations